Loading the records…
Loading the records…
The SCREENS for Cancer Act reauthorizes and expands national cancer screening programs for 2026-2030. This creates a structural volume tailwind for Labcorp ($LH) and Quest Diagnostics ($DGX) as the primary processors of screening lab work. Both stocks have been down over the past month on broader market weakness, not bill-specific news — the authorization provides a real federal program pipeline for incremental testing revenue once appropriations are secured.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Labcorp ($LH) and Quest Diagnostics ($DGX) are the direct beneficiaries of expanded NBCCEDP screening volumes. Both stocks have declined ~4-5% over the past week as part of a broader healthcare selloff, not a bill-specific signal. The authorization provides a federal program revenue pipeline that will sustain incremental testing volumes through 2030 once funded. Investors should watch appropriation markup sessions for the actual dollar amounts. The 57 cosponsors and companion bill indicate meaningful bipartisan support, reducing legislative risk. Centene ($CNC), despite being up 63% over 30 days on its own earnings news, is a managed care operator not directly tied to NBCCEDP lab reimbursement and should not be included in this trade.
The SCREENS for Cancer Act of 2025 (HR2381) was introduced on March 26, 2025 by Rep. Morelle (D-NY) with 57 cosponsors. It reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026 through 2030, expanding the program's scope. The bill has been referred to the House Committee on Energy and Commerce and is in early legislative stage. A companion bill (S1866) has also been introduced in the Senate, increasing the probability of eventual passage.
The money trail: This is an authorization bill — it sets policy and spending ceilings, but does NOT appropriate actual money. Actual funding requires a separate HHS appropriations bill. However, NBCCEDP is a well-established program (created 1991) with bipartisan support, having served 6.4M+ people and provided 16.5M+ screening exams. Reauthorization signals continued federal commitment to cancer screening, which directly benefits the two dominant national lab processors: Labcorp and Quest Diagnostics. The bill text does not specify a new spending ceiling amount, so the incremental revenue will depend on the actual appropriations level.
The market data shows $LH down 4.79% and $DGX down 4.39% over the past 7 days as of the most recent data, but this reflects broader market weakness (HCA, a hospital operator, has dropped 9.61% over 30 days). The recent selloff is not bill-specific. Labcorp actually recovered 2.76% on April 30 alone, closing at $264.23 after hitting a 7-day low of $257.14 on April 29. Quest hit $189.32 on April 29 and bounced back to $195.46 on April 30.
The timeline: The bill must pass the House Energy and Commerce Committee, then the full House, then the Senate (where companion bill S1866 is pending), then be signed into law. Given the bipartisan nature of cancer screening programs, passage in the current Congress is likely but not guaranteed. Actual revenue impact for lab companies will lag by 12-24 months, as appropriations and state program expansions take time.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Matched on shared policy language across AI analyses, with ticker & timing weight
FIRE Cancer Act of 2026
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Colorectal Cancer Early Detection Act
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →